Literature DB >> 20074565

Isoform- and dose-sensitive feedback interactions between paired box 6 gene and delta-catenin in cell differentiation and death.

Jiao Zhang1, Jian-Ping Lu, David M Suter, Karl-Heinz Krause, M Elizabeth Fini, Baoan Chen, Qun Lu.   

Abstract

Pax6, a mammalian homolog of the Drosophila paired box gene family member expressed in stem and progenitor cells, resides at the top of the genetic hierarchy in controlling cell fates and morphogenesis. While Pax6 activation can lead to mitotic arrest, premature neurogenesis, and apoptosis, the underlying molecular mechanisms have not been resolved. Here we report that either Pax6(+5a) or Pax6(-5a) was sufficient to promote, whereas their knockdown reduced the expression of delta-catenin (CTNND2), a neural specific member of the armadillo/beta-catenin superfamily. Pax6(+5a) elicited stronger effects on delta-catenin than Pax6(-5a). Inducible Pax6(+5a) expression demonstrated a biphasic and dose-dependent regulation of delta-catenin expression and cell fates. A moderate upregulation of Pax6(+5a) promoted delta-catenin expression and induced neurite-like cellular protrusions, but increasing expression of Pax6(+5a) reversed these processes. Furthermore, sustained high expression of Pax6(+5a) triggered apoptosis as determined by the reduction of phospho-Bad, Bcl-2, survivin and procaspases, as well as the increases in Bax and cleaved poly(ADP-ribose) polymerase. Importantly, re-introducing delta-catenin by ectopic expression elicited a feedback suppression on Pax6(+5a) expression and reduced Pax6(+5a) induced apoptosis. Therefore, delta-catenin expression is not only controlled by Pax6, but it also provides a feedback suppression mechanism for their functional interactions with important implications in cellular morphogenesis, apoptosis, and cancer. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074565      PMCID: PMC2885963          DOI: 10.1016/j.yexcr.2010.01.006

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  44 in total

Review 1.  Pax 6: mastering eye morphogenesis and eye evolution.

Authors:  W J Gehring; K Ikeo
Journal:  Trends Genet       Date:  1999-09       Impact factor: 11.639

2.  Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription.

Authors:  M E Hill; S L Asa; D J Drucker
Journal:  Mol Endocrinol       Date:  1999-09

3.  Pax 4 and 6 regulate gastrointestinal endocrine cell development.

Authors:  L I Larsson; L St-Onge; D M Hougaard; B Sosa-Pineda; P Gruss
Journal:  Mech Dev       Date:  1998-12       Impact factor: 1.882

4.  Presenilin 1 interaction in the brain with a novel member of the Armadillo family.

Authors:  J Zhou; U Liyanage; M Medina; C Ho; A D Simmons; M Lovett; K S Kosik
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

5.  Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin.

Authors:  G Levesque; G Yu; M Nishimura; D M Zhang; L Levesque; H Yu; D Xu; Y Liang; E Rogaeva; M Ikeda; M Duthie; N Murgolo; L Wang; P VanderVere; M L Bayne; C D Strader; J M Rommens; P E Fraser; P St George-Hyslop
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

6.  Dissection of the transactivation function of the transcription factor encoded by the eye developmental gene PAX6.

Authors:  H K Tang; S Singh; G F Saunders
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

7.  Isolation of human delta-catenin and its binding specificity with presenilin 1.

Authors:  H Tanahashi; T Tabira
Journal:  Neuroreport       Date:  1999-02-25       Impact factor: 1.837

8.  The arm-repeat protein NPRAP (neurojungin) is a constituent of the plaques of the outer limiting zone in the retina, defining a novel type of adhering junction.

Authors:  R Paffenholz; C Kuhn; C Grund; S Stehr; W W Franke
Journal:  Exp Cell Res       Date:  1999-08-01       Impact factor: 3.905

9.  Lune/eye gone, a Pax-like protein, uses a partial paired domain and a homeodomain for DNA recognition.

Authors:  S Jun; R V Wallen; A Goriely; B Kalionis; C Desplan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  The role of Pax-6 in eye and nasal development.

Authors:  J C Grindley; D R Davidson; R E Hill
Journal:  Development       Date:  1995-05       Impact factor: 6.868

View more
  9 in total

1.  Discovery and assessment of conserved Pax6 target genes and enhancers.

Authors:  Pedro Coutinho; Sofia Pavlou; Shipra Bhatia; Kevin J Chalmers; Dirk A Kleinjan; Veronica van Heyningen
Journal:  Genome Res       Date:  2011-05-26       Impact factor: 9.043

2.  PAX6 overexpression is associated with the poor prognosis of invasive ductal breast cancer.

Authors:  Xianghou Xia; Wenjuan Yin; Xiping Zhang; Xingfei Yu; Chen Wang; Shenhua Xu; Weiliang Feng; Hongjian Yang
Journal:  Oncol Lett       Date:  2015-06-29       Impact factor: 2.967

3.  δ-Catenin dysregulation in cancer: interactions with E-cadherin and beyond.

Authors:  Qun Lu
Journal:  J Pathol       Date:  2010-10       Impact factor: 7.996

4.  Identification of myopia-associated WNT7B polymorphisms provides insights into the mechanism underlying the development of myopia.

Authors:  Masahiro Miyake; Kenji Yamashiro; Yasuharu Tabara; Kenji Suda; Satoshi Morooka; Hideo Nakanishi; Chiea-Chuen Khor; Peng Chen; Fan Qiao; Isao Nakata; Yumiko Akagi-Kurashige; Norimoto Gotoh; Akitaka Tsujikawa; Akira Meguro; Sentaro Kusuhara; Ozen Polasek; Caroline Hayward; Alan F Wright; Harry Campbell; Andrea J Richardson; Maria Schache; Masaki Takeuchi; David A Mackey; Alex W Hewitt; Gabriel Cuellar; Yi Shi; Luling Huang; Zhenglin Yang; Kim Hung Leung; Patrick Y P Kao; Maurice K H Yap; Shea Ping Yip; Muka Moriyama; Kyoko Ohno-Matsui; Nobuhisa Mizuki; Stuart MacGregor; Veronique Vitart; Tin Aung; Seang-Mei Saw; E-Shyong Tai; Tien Yin Wong; Ching-Yu Cheng; Paul N Baird; Ryo Yamada; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Nat Commun       Date:  2015-03-31       Impact factor: 14.919

5.  Loss of δ-catenin function in severe autism.

Authors:  Tychele N Turner; Kamal Sharma; Edwin C Oh; Yangfan P Liu; Ryan L Collins; Maria X Sosa; Dallas R Auer; Harrison Brand; Stephan J Sanders; Daniel Moreno-De-Luca; Vasyl Pihur; Teri Plona; Kristen Pike; Daniel R Soppet; Michael W Smith; Sau Wai Cheung; Christa Lese Martin; Matthew W State; Michael E Talkowski; Edwin Cook; Richard Huganir; Nicholas Katsanis; Aravinda Chakravarti
Journal:  Nature       Date:  2015-03-25       Impact factor: 49.962

6.  Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

Authors:  Meng Jin; Daili Gao; Rongchun Wang; Attila Sik; Kechun Liu
Journal:  Oncol Rep       Date:  2020-06-11       Impact factor: 3.906

7.  The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling.

Authors:  Dong-Ming Wu; Ting Zhang; Ya-Bin Liu; Shi-Hua Deng; Rong Han; Teng Liu; Jing Li; Ying Xu
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

8.  A new genome scan for primary nonsyndromic vesicoureteric reflux emphasizes high genetic heterogeneity and shows linkage and association with various genes already implicated in urinary tract development.

Authors:  J M Darlow; M G Dobson; R Darlay; C M Molony; M Hunziker; A J Green; H J Cordell; P Puri; D E Barton
Journal:  Mol Genet Genomic Med       Date:  2013-07-07       Impact factor: 2.183

9.  Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells.

Authors:  Bo Meng; Yisong Wang; Bin Li
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.